WKN: | 966025 |
ISIN: | DE0009660258 |
Region: | Deutschland |
Sektor: | Logistik |
EQS-News: Galimedix, Inc. / Key word(s): Study results Progress in clinical development for Alzheimer´s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta... ...weiterlesen